Table 2.
Demographics and Laboratory tests of SCD and ALS patients.
| SCD(N=65) | ALS(N=65) | P | |
|---|---|---|---|
| Age | 58.54 ± 14.18 | 56.55 ± 8.87 | 0.341 |
| Gender(M/F) | 47/18 | 47/18 | 1.000 |
| RBC counting (1012/L) | 3.81 ± 0.91 | 4.50 ± 0.48 | <0.001 |
| Hb(g/L) | 125.71 ± 23.44 | 137.85 ± 14.50 | 0.001 |
| MCV(fl) | 98.41 ± 9.63 | 90.61 ± 5.13 | <0.001 |
| Vit B12(pg/mL) | 507.55(86.13–1235.75) | 890.45(562.65–1379.5) | 0.051 |
| Folic acid(ng/ml) | 11.30 ± 6.27 | 8.07 ± 4.03 | 0.009 |
| Hcy(umol/L) | 17.20(10.43–50.38) | 11.00(7.88–14.85) | 0.004 |
| Pepsinogen 1(ng/ml) | 8.00(3.85–63.30) | 54.80(43.55–75.80) | 0.005 |
| Pepsinogen 2(ng/ml) | 6.80(5.20–9.50) | 10.40(6.40–14.30) | <0.001 |
| PG1/2 ratio | 1.67(0.74–6.59) | 5.56(4.34–7.98) | <0.001 |
SCD, subacute combined degeneration; ALS, amyotrophic lateral sclerosis; M/F, male/female; RBC, red blood cell; Hb, hemoglobin; MCV, mean corpuscular volume; Hcy, homocysteine; PG1/2, pepsinogen 1/pepsinogen 2.